Fibrinogen 350mg/5ml solution for sealant vials
Requires a prescription from a doctor or prescriber
Fibrinogen concentrate (human) is a hematological agent.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
MHRA licensed products
View all licensed products for Fibrinogen human on the MHRA register
Fibrinogen 350mg/5ml solution for sealant vials
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(1)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 3 · Randomised trials: 1 · 1947–2026
Showing the 50 most relevant studies, sorted by most relevant.
Szabo YZ, Nishimi K, Smirnova M, et al.
2026
IntroductionConverging evidence implicates elevated inflammation in the pathophysiology of depression and its medical comorbidities. Despite known sex differences in both inflammatory activity and depression, a dedicated large-scale review of these differences is lacking.MethodsWe conducted a sex-stratified systematic review and meta-analysis of studies examining associations between depression and blood-based inflammatory markers in adult humans. Searches of PubMed, PsycINFO, and Scopus, and reference treeing, yielded 124 eligible papers including data from 423,421 participants (53% female). Analyses focused on depression and inflammatory markers C-reactive protein (CRP), interleukin (IL)-6, tumor necrosis factor (TNF)-α, IL-1β, and fibrinogen. Sex-stratified meta-analyses and meta regressions for the effects of sex were conducted, separately for cross-sectional and longitudinal designs.ResultsCross-sectionally, depression was modestly associated with higher levels of all markers combined in both females (Cohen's d = 0.06, 95% CI [0.03-0.10]) and males (Cohen's d = 0.14, 95% CI [0.09-0.19]). Depression was associated with elevated IL-6 in females, and elevated CRP and IL-6 in males. Longitudinally, elevated IL-6 was associated with subsequent depression among females and elevated CRP was associated with depression in males, whereas depression was not associated with subsequent inflammation in either sex.ConclusionOverall, results indicated modest associations between depression and elevated inflammation in both sexes, with slightly stronger associations in males. Associations between specific inflammatory markers (i.e., IL-6 in females and CRP in males) and subsequent depression differed by sex. These findings highlight the cross-sex relevance of inflammation in depression, and subtle sex differences in directionality and specific markers.
Abstract licence: CC BY
Razi B, Eslami M, Hatami A, et al.
2026
- Lipoproteins
- Fibrinogen
- Blood Component Removal
Jun Wang, Miguel F. Sanmamed, Ila Datar, et al.
Cell, 2018
- Lymphocyte Activation Gene 3 Protein
- Histocompatibility Antigens Class II
- Cell Line
Taru Tukiainen, Katherine H. Huang, Kristin G. Ardlie, et al.
Nature, 2017
- Alleles
- Chromosomes, Human
- Disease
Franchini, Massimo, Liumbruno, Giancarlo M., Marano, Giuseppe, et al.
SIMTI Servizi Sri, 2017
Bang YJ, Oh CS, Lee DK, et al.
2026
Natalia Wegner, Robin Wait, Aneta Sroka, et al.
Arthritis & Rheumatism, 2010
- Protein-Arginine Deiminases
- Amino Acid Sequence
- Arthritis, Rheumatoid
Justin M. Kollman, L. Pandi, M.R. Sawaya, et al.
Biochemistry, 2009
- Chromatography, DEAE-Cellulose
- Electrophoresis, Polyacrylamide Gel
- Fibrinogen
Zhou J. Deng, Mingtao Liang, István Tóth, et al.
ACS Nano, 2012
- Acrylic Resins
- Binding Sites
- Fibrinogen
Junjie Qin, Ruiqiang Li, Jeroen Raes, et al.
Nature, 2010
- Bacteria
- Denmark
- Feces
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
Fibrinogen (factor I) is a soluble plasma glycoprotein with a molecular weight of about 340 kDa.
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
[L41065]
It is also indicated for fibrinogen supplementation in bleeding patients with acquired fibrinogen deficiency.
[L41065]
In combination with thrombin, it is used indicated as an adjunct to hemostasis for mild to moderate bleeding in adults undergoing surgery when control of bleeding by standard surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical.
[L12936][L12939]
Known interactions with other medications. Always consult a healthcare professional.
Showing 50 of 91 interactions
ATC B02BB01
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Fibrinogen human
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
ATC classifications (Wikidata)
Linked open data from Wikidata (Q22075876), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication.